New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
10:00 EDTARG, HTZ, BBBY, RBA, TITN, WSO, UN, TMK, TAM, SPH, STCK, SJR, REGN, PL, MHFI, PETM, XONE, CRUS, APOOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Airgas (ARG) downgraded to Sell from Neutral at Goldman... Cirrus Logic (CRUS) downgraded to Underperform from Sector Perform at Pacific Crest... ExOne (XONE) downgraded to Hold from Buy at Canaccord... McGraw Hill Financial (MHFI) downgraded to Hold from Buy at Benchmark Co... PetSmart (PETM) downgraded to Neutral from Buy at UBS... Protective Life (PL) downgraded to Market Perform from Outperform at Raymond James... Regeneron (REGN) downgraded to Market Perform from Outperform at BMO Capital... Shaw Communications (SJR) downgraded to Neutral from Buy at BofA/Merrill... Stock Building Supply (STCK) downgraded to Neutral from Buy at Goldman... Suburban Propane (SPH) downgraded to Sell from Neutral at Goldman... Taminco (TAM) downgraded to Neutral from Buy at Goldman... Torchmark (TMK) downgraded to Underperform from Market Perform at Raymond James... Unilever (UN) downgraded to Underweight from Neutral at JPMorgan... Watsco (WSO) downgraded to Sell from Neutral at Goldman... Titan Machinery (TITN) downgraded to Sell from Hold at Cantor... Ritchie Bros. (RBA) downgraded to Sell from Hold at Cantor... Bed Bath & Beyond (BBBY) downgraded to Neutral from Buy at Gilford Securities... Hertz (HTZ) downgraded to Neutral from Buy at Goldman... Apollo Global (APO) downgraded to Perform from Outperform at Oppenheimer.
News For ARG;CRUS;XONE;PETM;MHFI;PL;REGN;SJR;STCK;SPH;TAM;TMK;UN;WSO;TITN;RBA;BBBY;HTZ;APO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 20, 2014
18:51 EDTCRUSOn The Fly: After Hours Movers
Subscribe for More Information
18:22 EDTCRUSSkyworks Solutions, Cirrus Logic, others higher after Apple reports Q4 results
The following stocks are moving higher in the after hours following Apple's Q4 results: ARM Holdings (ARMH) is up 1.1%, Skyworks Solutions (SWKS) is higher by 2.2% ,NXP Semiconductors (NXPI), up 2.28%,Cirrus Logic (CRUS) is up 2%, RF Micro Devices (RFMD) gains 1.53% and Avago Technologies (AVGO) is up 1.17%.
08:58 EDTHTZJana Partners reports 7% stake in Hertz, says may engage in talks
Subscribe for More Information
07:16 EDTREGNAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.
07:10 EDTREGNAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
07:02 EDTREGNRegeneron Sanofi begins dosing in Phase 3 study of dupilumab
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis, or AD, that is not adequately controlled with topical AD medications. LIBERTY AD CHRONOS, the first trial in the Phase 3 clinical program for dupilumab, is a randomized, double-blind, placebo-controlled, multi-national study with the primary objective of demonstrating the efficacy of dupilumab in adults with moderate to severe AD when administered concomitantly with topical corticosteroids through 16 weeks.
October 17, 2014
09:31 EDTRBARitchie Bros. downgraded to Mixed from Positive at OTR Global
09:06 EDTREGNAmgen files patent infringement lawsuit against Sanofi, Regeneron
Amgen (AMGN) announced that it filed a lawsuit in the United States District Court of Delaware against Sanofi (SNY), Aventisub, formerly doing business as Aventis Pharmaceuticals, and Regeneron Pharmaceuticals (REGN) for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741. These patents, which are owned by Amgen, describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9, or PCSK9. By its complaint, Amgen seeks an injunction to prevent the infringing manufacture, use and sale of Sanofi and Regeneron's alirocumab, a monoclonal antibody targeting PCSK9. Sanofi and Regeneron recently announced that they have completed Phase 3 clinical trials on alirocumab and intend to pursue regulatory approval to market alirocumab in the U.S. Amgen previously announced submission of a Biologics License Application to the FDA for evolocumab, its own investigational human monoclonal antibody to PCSK9, for the treatment of high cholesterol, on Aug. 28.
07:07 EDTREGNRegeneron announces EYLEA results from NIH study
Subscribe for More Information
October 16, 2014
13:31 EDTSJROttawa Convention Centre and Shaw Communications announce sponsorship deal
Subscribe for More Information
08:36 EDTREGNRegeneron Genetics Center announces new collaborations and appointments
Subscribe for More Information
October 15, 2014
08:34 EDTHTZHertz subsidiary Hertz Equipment Rental launches In Panama
Hertz' wholly owned subsidiary Hertz Equipment Rental Corporation has announced its launch in Panama City, Panama to deliver specialty equipment rental solutions for the construction, industrial, and government sectors.
October 14, 2014
08:04 EDTTMKDeutsche sees favorable risk/rewards in Insurance space
Subscribe for More Information
05:58 EDTHTZStocks with implied volatility above IV index mean; HTZ SD
Subscribe for More Information
October 13, 2014
06:03 EDTHTZStocks with implied volatility above IV index mean; HTZ MU
Subscribe for More Information
05:32 EDTAPOApollo Credit launches retail sector investment JV
Funds managed by affiliates of Apollo Global Management announce the launch of Alteri Investors, a new joint venture focused on financing opportunities arising across performing, stressed and distressed retail sector situations in Europe. Structured as a partnership between funds managed under Apollo’s credit business and a team led by former GA Europe CEO Gavin George, Alteri will initially focus on the United Kingdom and Germany and expects to invest in retailers through both debt and equity transactions, typically in the GBP 10M-GPB 50M range, with additional capacity for larger transactions. Alteri will also seek to lend to retailers directly, providing flexible asset-based financing, either in a senior or second-lien capacity. In addition to the scale, resources and capital funding that Apollo Credit expects to contribute to Alteri, the Joint Venture will draw upon the experience of Alteri Advisors, which comprises a team of highly experienced professionals, drawn in part from the former GA Europe business under the leadership of Gavin George.
October 10, 2014
15:43 EDTXONEExOne August volatility increases on sharp rally
Subscribe for More Information
11:40 EDTHTZStocks with call strike movement; HTZ AAL
Subscribe for More Information
08:05 EDTAPO21st Century Fox, Apollo Global agree to form content joint venture
Subscribe for More Information
08:03 EDTAPO21st Century Fox, Apollo Global form content joint venture
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use